Protenus - About the company
Protenus is an acquired company based in Baltimore (United States), founded in 2014 by Nicholas Culbertson. It operates as an AI-based insider threat detection and prevention solutions for healthcare sector. Protenus has raised $61M in funding from investors like Kaiser Permanente Ventures, Arthur Ventures and F-Prime Capital. The company has 53 active competitors, including 6 funded and 9 that have exited. Its top competitors include companies like Imprivata, Datavant and Clearwave.
Company Details
Protenus' product detects inappropriate EMR access in real-time focusing on insider threats based on a continuously updated baseline/threshold of the institution’s behavior. The solution comprises of AI-based analytics solution which operates on top of existing hospital systems and integrates with existing workflows. Technology is focused on visualizing clinical and administrative workflows to address unauthorized access at the moment of breach, monitoring employee behavior and patient privacy protection for minimizing the risk of lawsuits, fines, and reputational damage.
- Website
- protenus.com
- Registered Address
- Baltimore, Maryland
Key Metrics
Founded Year
2014
Location
Baltimore, United States
Stage
Acquired
Total Funding
$61M in 8 rounds
Latest Funding Round
Investors
Ranked
3rd among 53 active competitors
Employee Count
22 as on May 31, 2026
Exit Details
Acquired by Bluesight (Jan 09, 2025)
Legal entities associated with Protenus
Protenus is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
PROTENUS CIN: 383923513 , United States, Active | Dec 31, 1999 | - | 97 (As on Dec 31, 2024) | - |
PROTENUS, INC. CIN: 6621649 , United States, Active | Oct 21, 2022 | - | - | - |
Protenus's acquisition details
Protenus got acquired by Bluesight on Jan 09, 2025.
Click here to take a look at Protenus's acquisition in detail
Sign up to download Protenus' company profile
Protenus's funding and investors
Protenus has raised a total funding of $61M over 8 rounds. Its first funding round was on May 08, 2014. Its latest funding round was a Series D round on May 12, 2021 for $*****. 8 investors participated in its latest round. Protenus has 17 institutional investors.
Here is the list of recent funding rounds of Protenus:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 12, 2021 | 8303731 | Series D | 5010723 | 7585227 | 9494585 | 9721312 |
May 01, 2019 | 3516714 | Series C | 9814427 | 6140350 | 6932389 | |
Jan 16, 2018 | 1719207 | Series B | 9288611 | 5891590 |
View details of Protenus's funding rounds and investors
Protenus' founders and board of directors
Founder? Claim ProfileThe founders of Protenus is Nicholas Culbertson.
Here are the details of Protenus' key team members:
- Nicholas Culbertson: Co-Founder of Protenus.
View details of Protenus's Founder profiles and Board Members
Protenus' employee count trend
Protenus has 22 employees as of May 26. Here is Protenus's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Protenus's Competitors and alternates
Top competitors of Protenus include Imprivata, Datavant and Clearwave. Here is the list of Top 10 competitors of Protenus, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Imprivata 2002, Waltham (United States), Acquired | Cloud-based authentication and secure communication solutions for enterprises | $40.5M | 74/100 | |
2nd | Datavant 2017, San Francisco (United States), Series B | Provider of platform to access patient data securely | $83M | 70/100 | |
3rd | Protenus 2014, Baltimore (United States), Acquired | AI-based insider threat detection and prevention solutions for healthcare sector | $61M | 52/100 | |
4th | Clearwave 2004, Atlanta (United States), Series A | Patient engagement software optimizing healthcare workflows, revenue, and patient experience | $5.3M | 52/100 | |
5th | Phynd 2012, Dallas (United States), Acquired | Unified platform for sharing provider information across healthcare organizations | $21.5M | 44/100 | |
6th | Provider of the medical record management solution for healthcare providers | - | 42/100 | ||
7th | Digital platform revolutionizing access and management of medical information | $165K | 41/100 | ||
8th | Tools4ever 1999, Lynbrook (United States), Unfunded | Identity governance & Access Management Solutions | - | - | 41/100 |
9th | DocBuddy 2014, Denver (United States), Seed | Workflow streamlining & patient record accessing the solution | $2.39M | - | 39/100 |
10th | Sentillion 1998, Andover (United States), Acquired | Offers identity and access management solutions | $29.5M | 37/100 |
Looking for more details on Protenus's competitors? Click here to see the top ones
Protenus's Investments and acquisitions
Protenus has made no investments or acquisitions yet.
Reports related to Protenus
Here is the latest report on Protenus's sector:
News related to Protenus
•
Bluesight’s Acquisition of ProtenusGlobal Legal Chronicle•Jan 23, 2025•Bluesight, Protenus, Kirkland & Ellis, DLA Piper and 1 other
•
Bluesight acquires Protenus to add patient privacy monitoring featuresHospital Management•Jan 10, 2025•Bluesight, Protenus
•
Bluesight Expands Compliance Capabilities and Strengthens Platform through Acquisition of ProtenusSalesTech Star•Jan 09, 2025•Bluesight, Protenus
•
Protenus Granted Seventh Patent for Drug Diversion Surveillance TechnologyNewswire•Jul 18, 2024•Protenus
•
•
•
Protenus Granted Sixth Patent for Drug Diversion Surveillance TechnologyNewswire•Mar 26, 2024•Protenus
•
•
Protenus Granted Fifth New Patent for Drug Diversion Surveillance TechnologyNewswire•Oct 26, 2023•Protenus
•
Protenus Selected as One of the 2023 Best Places to Work in HealthcareACCESSWIRE•May 30, 2023•Protenus
Are you a Founder ?
FAQs about Protenus
Explore our recently published companies
- Cliodinamica - 2009 founded, Unfunded company
- Consultingwatson - 2014 founded, Unfunded company
- Grangegeo - United Kingdom based, Unfunded company
- Finito Northwest - United Kingdom based, Unfunded company
- Aquapicanco - 2007 founded, Unfunded company
- Mw-Kehitys - Unfunded company
